Orig3n
Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.
All edits
June 12, 2018
On June 12, 2018 Orig3n completed their series B funding round with an undisclosed amount of funding (of at least $14.4 million) from Haitong International Securities Group (lead investor), Vectr Ventures, Spectrum Health Ventures, Mountain Group Capital, MMIC Investment Holdings, LabCorp, KTB Ventures, Hatteras Venture Partners, Defta Partners, Alexandria Venture Investments, and 180 Degree Capital.
June 27, 2017
On June 27, 2017 Orig3n completed another venture capital round with $20 million in funding from Hatteras Venture Partners (lead investor), Syno Capital, Spectrum Health Ventures, MGC Venture Partners, LabCorp, KTB-Korus Fund, Defta Partners, and 180 Degree Capital.
December 12, 2015
On December 12, 2015 Orig3n completed their series A funding round with $12.5 million in funding from Syno Capital (lead investor), Hatteras Venture Partners, (lead investor), Mountain Group Capital, LabCorp, KTB-Korus Fund, Defta Partners, and 180 Degree Capital.
February 15, 2015
On February 15, 2015 Orig3n completed a venture capital funding round with $3.1 million in funding from Mountain Group Capital, KTB Ventures, Hatteras Venture Partners, and 180 Degrees Capital.
On February 15, 2015 Orig3n completed a venture capital funding round with $3.1 million in funding from Mountain Group Capital, KTB Ventures, Hatteras Venture Partners, and 180 Degrees Capital.
On December 12, 2015 Orig3n completed their series A funding round with $12.5 million in funding from Syno Capital (lead investor), Hatteras Venture Partners, (lead investor), Mountain Group Capital, LabCorp, KTB-Korus Fund, Defta Partners, and 180 Degree Capital.
On June 27, 2017 Orig3n completed another venture capital round with $20 million in funding from Hatteras Venture Partners (lead investor), Syno Capital, Spectrum Health Ventures, MGC Venture Partners, LabCorp, KTB-Korus Fund, Defta Partners, and 180 Degree Capital.
On June 12, 2018 Orig3n completed their series B funding round with an undisclosed amount of funding (of at least $14.4 million) from Haitong International Securities Group (lead investor), Vectr Ventures, Spectrum Health Ventures, Mountain Group Capital, MMIC Investment Holdings, LabCorp, KTB Ventures, Hatteras Venture Partners, Defta Partners, Alexandria Venture Investments, and 180 Degree Capital.
Find more companies like Orig3n
